To further clarify the role of Cyn in inhibiting PI3K/AKT signaling in IEC apoptosis, barrier damage, and colitis, we used Wortmannin, a potent, selective, and irreversible PI3K inhibitor (Moon et al., 2015). This evidence concerns the gene AKT1 and colitis.